Det konkluderes, at der ikke længere findes en potentiel alvorlig risiko for folkesundheden, og CHMP konkluderede, at produkterne er bioækvivalente, og at benefit/ risk- forholdet er positivt.
In conclusion a Potential Serious Risk to Public Health was no longer identified and the CHMP concluded that the products are bioequivalent and that the benefit-risk ratio is positive.